Effectiveness of stop‐smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Aim: To evaluate the population effectiveness of stop‐smoking medications while accounting for potential recall bias by controlling for quit attempt recency. Design: Prospective cohort survey. Setting: U nited K ingdom, C anada, A ustralia and the U nited S tates. Participants: A total of 7436 adult smokers (18+ years) selected via random digit dialling and interviewed as part of the I nternational T obacco C ontrol F our C ountry S urvey (ITC‐4) between 2002 and 2009. Primary analyses utilized the subset of respondents who participated in 2006 or later (n = 2550). Measurements: Continuous abstinence from smoking for 1 month/6 months. Findings: Among participants who recalled making a quit attempt within 1 month of interview, those who reported using varenicline, bupropion or nicotine patch were more likely to maintain 6‐month continuous abstinence from smoking compared to those who attempted to quit without medication [adjusted odds ratio (OR) 5.84, 95% confidence interval (CI) (2.12–16.12), 3.94 (0.87–17.80), 4.09 (1.72–9.74), respectively]; there were no clear effects for oral NRT use. Those who did not use any medication when attempting to quit tended to be younger, to be racial/ethnic minorities, to have lower incomes and to believe that medications do not make quitting easier. Conclusions: Consistent with evidence from randomized controlled trials, smokers in the United Kingdom, C anada, A ustralia and the United States are more likely to succeed in quit attempts if they use varenicline, bupropion or nicotine patch. Previous population studies that failed to find an effect failed to control adequately for important sources of bias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Generalized Estimating Equations
Hardin, J. W., & Hilbe, J. M. (2002) · doi:10.1201/9781420035285 · Cited by 1,766
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Nicotine replacement therapy for smoking cessation
Silagy, C., Lancaster, T., Stead, L., Mant, D., & Fowler, G. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub2 · Cited by 972
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub2 · Cited by 747
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567 · cited 1×
“Numerous randomized, placebo-controlled clinical trials have demonstrated that nicotine replacement therapy [1,2], bupropion [3] and varenicline [4] are efficacious in increasing the odds of smoking cessation, and clinical practice guidelines recommend the use of pharmacotherapy as a first-line agent for treating nico…”
Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation
Pierce, J. P. (2002) · JAMA · doi:10.1001/jama.288.10.1260 · Cited by 240 · cited 4×
“For example, Pierce & Gilpin reported that NRT is ineffective since becoming available over-thecounter (OTC) [17], Hyland et al.”
InfluentialImpact of UK policy initiatives on use of medicines to aid smoking cessation
West, R., DiMarino, M. E., Gitchell, J., & McNeill, A. (2005) · Tobacco Control · doi:10.1136/tc.2004.008649 · Cited by 92
Self-citationLe Strat, Y., Rehm, J., & Le Foll, B. (2011) · Tobacco Control · doi:10.1136/tc.2010.038703 · Cited by 67
Fix, B. V., Hyland, A., Rivard, C., McNeill, A., Fong, G. T., Borland, R., Hammond, D., & Cummings, K. M. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8010222 · Cited by 35
Self-citation
Cited by
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Nicotine replacement therapy versus control for smoking cessation
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub5 · Cited by 697
Kotz, D., Brown, J., & West, R. (2014) · Addiction · doi:10.1111/add.12429 · Cited by 283
West, R., Raw, M., McNeill, A., Stead, L., Aveyard, P., Bitton, J., Stapleton, J., McRobbie, H., Pokhrel, S., Lester‐George, A., et al. (2015) · Addiction · doi:10.1111/add.12998 · Cited by 272
Self-citationChung-Hall, J., Craig, L., Gravely, S., Sansone, N., & Fong, G. T. (2019) · Tobacco Control · doi:10.1136/tobaccocontrol-2018-054389 · Cited by 250
Self-citation
Metadata
- Authors
- Kasza, K. A., Hyland, A. J., Borland, R., McNeill, A. D., Bansal‐Travers, M., Fix, B. V., Hammond, D., Fong, G. T., & Cummings, K. M.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2012-08-14
- Volume
- 108
- Issue
- 1
- Pages
- 193-202
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W1571169387
- Cited by
- 85
- References
- 9
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.